Covered recipient · General Payments record
EVELYN RENTAS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,441.64
- Reported across 65 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $359.89 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $57.70 | 2 |
| ABBVIE INC. | $53.08 | 2 |
| Lilly USA, LLC | $43.02 | 2 |
| Novo Nordisk AS | $41.25 | 2 |
| Acerta Pharma LLC | $38.79 | 2 |
| Sumitomo Pharma America, Inc. | $27.86 | 1 |
| PhotoniCare Inc | $26.65 | 1 |
| EISAI INC. | $20.14 | 1 |
| PFIZER INC. | $19.38 | 1 |
| Amgen Inc. | $16.06 | 1 |
| Exact Sciences Corporation | $15.96 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.04 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105938140 | CMS |
| ABBVIE INC. | $32.04 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105938142 | CMS |
| Amgen Inc. | $16.06 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117363181 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.27 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105747623 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.52 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104310426 | CMS |
| Eisai Inc. | $20.14 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110744941 | CMS |
| Exact Sciences Corporation | $15.96 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114851940 | CMS |
| GlaxoSmithKline, LLC. | $33.28 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116702773 | CMS |
| GlaxoSmithKline, LLC. | $24.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116406137 | CMS |
| Lilly USA, LLC | $19.23 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136174336 | CMS |
| Lilly USA, LLC | $23.79 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134970923 | CMS |
| Novo Nordisk Inc | $21.84 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097453007 | CMS |
| Novo Nordisk Inc | $19.41 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096607003 | CMS |
| PFIZER INC. | $19.38 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131650543 | CMS |
| PhotoniCare Inc | $26.65 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1072571104 | CMS |
| Sumitomo Pharma America, Inc. | $27.86 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148909170 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.